BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37985734)

  • 1. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans species complex from China, including the diploid VNIII isolates from HIV-infected patients in Chongqing region.
    Zhang L; Wang S; Hong N; Li M; Liu Y; Zhou T; Peng Y; Hu C; Li X; Zhang Z; Guo M; Cogliati M; Hitchcock M; Xu J; Chen M; Liao G
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37985734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic diversity and antifungal susceptibility of environmental isolates of Cryptococcus neoformans from the Yangtze River Delta region of East China.
    Chen M; Wang Y; Li Y; Hong N; Zhu X; Pan W; Liao W; Xu J; Du J; Chen J
    Med Mycol; 2021 Jul; 59(7):653-663. PubMed ID: 33269400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
    Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
    Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China.
    Hong N; Chen M; Xu N; Al-Hatmi AMS; Zhang C; Pan WH; Hagen F; Boekhout T; Xu J; Zou XB; Liao WQ
    Mycoses; 2019 Feb; 62(2):171-180. PubMed ID: 30341799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of Congo.
    Bive BZ; Sacheli R; Situakibanza Nani-Tuma H; Kabututu Zakayi P; Ka A; Mbula Mambimbi M; Muendele G; Boreux R; Landu N; Nzanzu Mudogo C; M'Buze PR; Moutschen M; Meyer W; Mvumbi Lelo G; Hayette MP
    PLoS One; 2022; 17(5):e0267842. PubMed ID: 35587939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and antifungal susceptibilities of Cryptococcus species isolates from HIV and non-HIV patients in Southwest China.
    Wu SY; Kang M; Liu Y; Chen ZX; Xiao YL; He C; Ma Y
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):287-295. PubMed ID: 32895755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
    Prakash A; Sundar G; Sharma B; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2020 Mar; 63(3):284-293. PubMed ID: 31820495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China.
    Fan X; Xiao M; Chen S; Kong F; Dou HT; Wang H; Xiao YL; Kang M; Sun ZY; Hu ZD; Wan Z; Chen SL; Liao K; Chu YZ; Hu TS; Zou GL; Hou X; Zhang L; Zhao YP; Xu YC; Liu ZY
    Clin Microbiol Infect; 2016 Oct; 22(10):887.e1-887.e9. PubMed ID: 27432767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of the Global Multilocus Genotypes of the Human Pathogenic Yeast
    Hitchcock M; Xu J
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360282
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
    Bive BZ; Sacheli R; Mudogo CN; Zakayi PK; Bontems S; Lelo GM; Hayette MP
    J Mycol Med; 2023 Nov; 33(4):101428. PubMed ID: 37651769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017.
    Fang LF; Zhang PP; Wang J; Yang Q; Qu TT
    Braz J Infect Dis; 2020; 24(1):7-12. PubMed ID: 31870760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
    Kassi FK; Drakulovski P; Bellet V; Roger F; Chabrol A; Krasteva D; Doumbia A; Landman R; Kakou A; Reynes J; Delaporte E; Menan HEI; Bertout S
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007812. PubMed ID: 31738768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011-2021.
    Ordaya EE; Abu Saleh OM; Vergidis P; Deml SM; Wengenack NL; Fida M
    Mycoses; 2024 Jan; 67(1):e13691. PubMed ID: 38214377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-locus sequence typing reveals genotypic similarity in Nigerian
    Chidebelu PE; Nweze EI; Meis JF; Cogliati M; Hagen F
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34665109
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China.
    Li M; Liao Y; Chen M; Pan W; Weng L
    Braz J Infect Dis; 2012; 16(2):175-9. PubMed ID: 22552461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Network of Uruguay.
    Puime CA; Bórmida V; Pan D
    Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37336574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.
    Herkert PF; Meis JF; Lucca de Oliveira Salvador G; Rodrigues Gomes R; Aparecida Vicente V; Dominguez Muro M; Lameira Pinheiro R; Lopes Colombo A; Vargas Schwarzbold A; Sakuma de Oliveira C; Simão Ferreira M; Queiroz-Telles F; Hagen F
    J Med Microbiol; 2018 Apr; 67(4):560-569. PubMed ID: 29461182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and antifungal susceptibility of Serbian Cryptococcus neoformans isolates.
    Arsic Arsenijevic V; Pekmezovic MG; Meis JF; Hagen F
    Mycoses; 2014 Jun; 57(6):380-7. PubMed ID: 24438323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
    Bertout S; Drakulovski P; Kouanfack C; Krasteva D; Ngouana T; Dunyach-Rémy C; Dongtsa J; Aghokeng A; Delaporte E; Koulla-Shiro S; Reynes J; Mallié M
    Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.